These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 29464358)

  • 21. Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank.
    Chen DC; Lu K; Scherzer R; Lees JS; Rutherford E; Mark PB; Potok OA; Rifkin DE; Ix JH; Shlipak MG; Estrella MM
    Kidney Med; 2024 Apr; 6(4):100796. PubMed ID: 38567244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discrepancies between Cystatin C-Based and Creatinine-Based eGFR.
    Farrington DK; Surapaneni A; Matsushita K; Seegmiller JC; Coresh J; Grams ME
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1143-1152. PubMed ID: 37339177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creatinine- and cystatin C-based estimated glomerular filtration rate slopes for the prediction of kidney outcome: a comparative retrospective study.
    Kim S; Hwang S; Jang HR; Sohn I; Ahn HS; Park HD; Huh W; Jin DC; Kim YG; Kim DJ; Oh HY; Lee JE
    BMC Nephrol; 2019 Jun; 20(1):214. PubMed ID: 31185945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discrepancy between estimated glomerular filtration rate by creatinine versus cystatin C in different patient care settings.
    Liu L; Chang DY; Lewandrowski KB; Dighe AS
    Clin Biochem; 2024 Oct; 131-132():110801. PubMed ID: 39029611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Creatinine versus cystatin C for renal function-based mortality prediction in an elderly cohort: The Northern Manhattan Study.
    Willey JZ; Moon YP; Husain SA; Elkind MSV; Sacco RL; Wolf M; Cheung K; Wright CB; Mohan S
    PLoS One; 2020; 15(1):e0226509. PubMed ID: 31940363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimated GFR Accuracy When Cystatin C- and Creatinine-Based Estimates Are Discrepant in Older Adults.
    Potok OA; Rifkin DE; Ix JH; Shlipak MG; Satish A; Schneider A; Mielke N; Schaeffner E; Ebert N
    Kidney Med; 2023 May; 5(5):100628. PubMed ID: 37168389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Difference Between Cystatin C- and Creatinine-Based Estimated GFR and Associations With Frailty and Adverse Outcomes: A Cohort Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Potok OA; Ix JH; Shlipak MG; Katz R; Hawfield AT; Rocco MV; Ambrosius WT; Cho ME; Pajewski NM; Rastogi A; Rifkin DE
    Am J Kidney Dis; 2020 Dec; 76(6):765-774. PubMed ID: 32682697
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance of the 2021 Race-Free CKD-EPI Creatinine- and Cystatin C-Based Estimated GFR Equations Among Kidney Transplant Recipients.
    Hundemer GL; White CA; Norman PA; Knoll GA; Tangri N; Sood MM; Hiremath S; Burns KD; McCudden C; Akbari A
    Am J Kidney Dis; 2022 Oct; 80(4):462-472.e1. PubMed ID: 35588905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
    Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
    Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estimated Glomerular Filtration Rate (eGFR) based on cystatin C was associated with increased risk of hip and proximal humerus fractures in women and decreased risk of hip fracture in men, whereas eGFR based on creatinine was not associated with fracture risk in both sexes: The Tromsø Study.
    Nordvåg SK; Solbu MD; Melsom T; Nissen FI; Andreasen C; Borgen TT; Eriksen BO; Joakimsen RM; Bjørnerem Å
    Bone; 2021 Jul; 148():115960. PubMed ID: 33864977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The clinical utility and cost impact of cystatin C measurement in the diagnosis and management of chronic kidney disease: A primary care cohort study.
    Shardlow A; McIntyre NJ; Fraser SDS; Roderick P; Raftery J; Fluck RJ; McIntyre CW; Taal MW
    PLoS Med; 2017 Oct; 14(10):e1002400. PubMed ID: 29016597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Estimated GFR Calculated Using Race-Free Equations With Kidney Failure and Mortality by Black vs Non-Black Race.
    Gutiérrez OM; Sang Y; Grams ME; Ballew SH; Surapaneni A; Matsushita K; Go AS; Shlipak MG; Inker LA; Eneanya ND; Crews DC; Powe NR; Levey AS; Coresh J;
    JAMA; 2022 Jun; 327(23):2306-2316. PubMed ID: 35667006
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive effect of estimated glomerular filtrate rate by creatinine or cystatin C on mortality in patients with coronary artery disease.
    Chen S; Zhou Y; Liang G; Wu W; Huang Z; Shi L; Gao Y; Gu X; Wang D
    Ren Fail; 2024 Dec; 46(1):2327494. PubMed ID: 38566467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing GFR Estimating Equations Using Cystatin C and Creatinine in Elderly Individuals.
    Fan L; Levey AS; Gudnason V; Eiriksdottir G; Andresdottir MB; Gudmundsdottir H; Indridason OS; Palsson R; Mitchell G; Inker LA
    J Am Soc Nephrol; 2015 Aug; 26(8):1982-9. PubMed ID: 25527647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coefficient of Determination between Estimated and Measured Renal Function in Japanese Patients with Sarcopenia May Be Improved by Adjusting for Muscle Mass and Sex: A Prospective Study.
    Nakatani S; Maeda K; Akagi J; Ichigi M; Murakami M; Harada Y; Utsumi S; Fukunaga M; Narita Y; Kondo Y; Ishitsuka Y; Irie T; Kadowaki D; Hirata S
    Biol Pharm Bull; 2019 Aug; 42(8):1350-1357. PubMed ID: 31167988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordances Between Creatinine- and Cystatin C-Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice.
    Carrero JJ; Fu EL; Sang Y; Ballew S; Evans M; Elinder CG; Barany P; Inker LA; Levey AS; Coresh J; Grams ME
    Am J Kidney Dis; 2023 Nov; 82(5):534-542. PubMed ID: 37354936
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overestimation of glomerular filtration rate calculated from creatinine as compared with cystatin C in patients with type 2 diabetes receiving sodium-glucose cotransportor 2 inhibitors.
    Choosongsang P; Soonthornpun S
    Diabet Med; 2022 Jan; 39(1):e14659. PubMed ID: 34309941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in the prevalence of reduced GFR in the United States: a comparison of creatinine- and cystatin C-based estimates.
    Grams ME; Juraschek SP; Selvin E; Foster MC; Inker LA; Eckfeldt JH; Levey AS; Coresh J
    Am J Kidney Dis; 2013 Aug; 62(2):253-60. PubMed ID: 23619125
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of Cystatin C Level for Risk Stratification in Adults With Chronic Kidney Disease.
    Lees JS; Rutherford E; Stevens KI; Chen DC; Scherzer R; Estrella MM; Sullivan MK; Ebert N; Mark PB; Shlipak MG
    JAMA Netw Open; 2022 Oct; 5(10):e2238300. PubMed ID: 36282503
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GFR estimated with creatinine rather than cystatin C is more reflective of the true risk of adverse outcomes with low GFR in kidney transplant recipients.
    Keddis MT; Howard MR; Galapia L; Barreto EF; Zhang N; Butterfield RJ; Rule AD
    Nephrol Dial Transplant; 2023 Jul; 38(8):1898-1906. PubMed ID: 36646435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.